Nothing Special   »   [go: up one dir, main page]

ATE857T1 - PROCESS FOR THE PRODUCTION OF MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING THEM. - Google Patents

PROCESS FOR THE PRODUCTION OF MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING THEM.

Info

Publication number
ATE857T1
ATE857T1 AT79104391T AT79104391T ATE857T1 AT E857 T1 ATE857 T1 AT E857T1 AT 79104391 T AT79104391 T AT 79104391T AT 79104391 T AT79104391 T AT 79104391T AT E857 T1 ATE857 T1 AT E857T1
Authority
AT
Austria
Prior art keywords
membrane proteins
neisseria meningitidis
production
vaccine containing
optionally
Prior art date
Application number
AT79104391T
Other languages
German (de)
Inventor
Torsten Bertil Dr. Helting
Gerhard Dr. Guthoehrlein
Original Assignee
Behringwerke Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Aktiengesellschaft filed Critical Behringwerke Aktiengesellschaft
Application granted granted Critical
Publication of ATE857T1 publication Critical patent/ATE857T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Process for the isolation of membrane proteins from Neisseria meningitidis which comprises treating the organism with the aqueous solution of a detergent in a concentration of 0.1 to 2% w/v for 15 minutes to 24 hours, allowing the mixture to stand, optionally with agitation, separating the extract from the bacterial residue and optionally carrying out a further purification.
AT79104391T 1978-11-11 1979-11-08 PROCESS FOR THE PRODUCTION OF MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING THEM. ATE857T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782848965 DE2848965A1 (en) 1978-11-11 1978-11-11 METHOD FOR PRODUCING MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING THEM
EP79104391A EP0011243B1 (en) 1978-11-11 1979-11-08 Process for preparing membrane proteins from neisseria meningitidis and vaccines containing them

Publications (1)

Publication Number Publication Date
ATE857T1 true ATE857T1 (en) 1982-04-15

Family

ID=6054405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79104391T ATE857T1 (en) 1978-11-11 1979-11-08 PROCESS FOR THE PRODUCTION OF MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING THEM.

Country Status (9)

Country Link
EP (1) EP0011243B1 (en)
JP (1) JPS5566519A (en)
AT (1) ATE857T1 (en)
AU (1) AU533386B2 (en)
CA (1) CA1142083A (en)
DE (2) DE2848965A1 (en)
DK (1) DK154841C (en)
ES (1) ES485715A1 (en)
IL (1) IL58673A (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH074267B1 (en) * 1982-12-02 1995-01-25 Univ Rockefeller
US7118757B1 (en) 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
EP2796148A3 (en) 1998-05-29 2015-02-25 Novartis Vaccines and Diagnostics, Inc. Combination meningitidis B/C vaccines
EP1860191A3 (en) 1999-05-19 2008-02-13 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
PT2289545T (en) 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Supplemented omv vaccine against meningococcus
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
KR20050039839A (en) * 2002-08-02 2005-04-29 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
CU23313A1 (en) 2002-11-27 2008-09-25 Inst Finlay Ct De Investigacia MÃ0 / 00 METHOD OF OBTAINING COCLEAR STRUCTURES VACCINAL COMPOSITIONS AND ADJUSTS BASED ON COCLEAR STRUCTURES AND THEIR INTERMEDIARIES
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
WO2005064021A2 (en) * 2003-12-23 2005-07-14 Glaxosmithkline Biologicals S.A. Vaccine
GB0419627D0 (en) 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
EP2032160B2 (en) 2006-06-12 2013-04-03 GlaxoSmithKline Biologicals S.A. Vaccine
WO2009050586A1 (en) 2007-10-19 2009-04-23 Novartis Ag Meningococcal vaccine formulations
US9579372B2 (en) 2008-02-21 2017-02-28 Glaxosmithkline Biologicals Sa Meningococcal fHBP polypeptides
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
JP2012512240A (en) 2008-12-17 2012-05-31 ノバルティス アーゲー Meningococcal vaccine containing hemoglobin receptor
US9517263B2 (en) 2009-06-10 2016-12-13 Glaxosmithkline Biologicals Sa Benzonaphthyridine-containing vaccines
JP2013502918A (en) 2009-08-27 2013-01-31 ノバルティス アーゲー Hybrid polypeptide comprising Neisseria meningitidis fHBP sequence
EP2470205A1 (en) 2009-08-27 2012-07-04 Novartis AG Adjuvant comprising aluminium, oligonucleotide and polycation
TWI445708B (en) 2009-09-02 2014-07-21 Irm Llc Compounds and compositions as tlr activity modulators
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
EP2483390A2 (en) 2009-09-30 2012-08-08 Novartis AG Expression of meningococcal fhbp polypeptides
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
CA2784580A1 (en) 2009-12-15 2011-07-14 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
EP2544713A1 (en) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Immunogenic composition
JP2013522287A (en) 2010-03-18 2013-06-13 ノバルティス アーゲー Adjuvated vaccine for serogroup B meningococcus
EA031379B1 (en) 2010-03-23 2018-12-28 Новартис Аг Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
BR112013005626B1 (en) 2010-09-10 2022-07-26 Glaxosmithkline Biologicals Sa MENINGOCOCUS, PROCESS FOR THE PREPARATION OF A MENINGOCOCCAL STRAIN, EXTERNAL MEMBRANE VESICLES, IMMUNOGENIC PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOSITION
EP2707009A1 (en) 2011-05-12 2014-03-19 Novartis AG Antipyretics to enhance tolerability of vesicle-based vaccines
MX2014008988A (en) 2012-02-02 2014-08-27 Novartis Ag Promoters for increased protein expression in meningococcus.
ES2750366T3 (en) 2012-03-08 2020-03-25 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines
RU2644340C2 (en) 2012-06-14 2018-02-08 Новартис Аг Vaccines for serogroup x meningococcus
CN104602705A (en) 2012-09-06 2015-05-06 诺华股份有限公司 Combination vaccines with serogroup b meningococcus and D/T/P
WO2014044728A1 (en) 2012-09-18 2014-03-27 Novartis Ag Outer membrane vesicles
SI3110442T1 (en) 2014-02-28 2021-01-29 Glaxosmithkline Biologicals S.A. Modified meningococcal fhbp polypeptides
AU2017321039B2 (en) 2016-09-02 2021-03-18 Glaxosmithkline Biologicals Sa Vaccines for Neisseria gonorrhoeae
TWI814739B (en) 2017-09-08 2023-09-11 美商艾弗洛生物科技股份有限公司 Bacterial extracellular vesicles
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
WO2020094580A1 (en) 2018-11-06 2020-05-14 Glaxosmithkline Biologicals Sa Immunogenic compositions
EP3799884A1 (en) 2019-10-01 2021-04-07 GlaxoSmithKline Biologicals S.A. Immunogenic compositions
GB202115072D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202211033D0 (en) 2022-07-28 2022-09-14 Glaxosmithkline Biologicals Sa Purification process

Also Published As

Publication number Publication date
IL58673A0 (en) 1980-02-29
JPS5566519A (en) 1980-05-20
DK154841B (en) 1988-12-27
EP0011243A1 (en) 1980-05-28
JPS6350332B2 (en) 1988-10-07
AU533386B2 (en) 1983-11-24
DE2962526D1 (en) 1982-05-27
ES485715A1 (en) 1980-05-16
IL58673A (en) 1983-02-23
AU5268279A (en) 1980-05-15
DK475779A (en) 1980-05-12
EP0011243B1 (en) 1982-04-14
DK154841C (en) 1989-06-05
DE2848965A1 (en) 1980-05-22
CA1142083A (en) 1983-03-01

Similar Documents

Publication Publication Date Title
ATE857T1 (en) PROCESS FOR THE PRODUCTION OF MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING THEM.
DE3767077D1 (en) METHOD FOR SEPARATING CHOLESTEROL FROM FAT SUBSTANCES OF ANIMAL ORIGIN AND LOW CHOLESTEROL FAT SUBSTANCES.
DE69224124D1 (en) Process for the preparation of dihomo-gamma-linolenic acid and the lipid contained therein
ATE69927T1 (en) PROCESS FOR PRODUCTION OF A WHEY PRODUCT WITH REDUCED ALLERGENCY.
DE3675239D1 (en) METHOD FOR PRODUCING AMINOPROPYLALCOXYSILANES.
ATE944T1 (en) PROCESS FOR THE PRODUCTION OF BONE REPLACEMENT MATERIAL WITH IMPROVED BIOLOGICAL STABILITY BASED ON COLLAGEN AND THE OBTAINED BONE REPLACEMENT MATERIAL.
DE3876477D1 (en) METHOD FOR PRODUCING OR EXTRACING AMINO ACIDS FROM DUENGER.
DE60107446D1 (en) PURIFIED COCHINEAL PIGMENT AND METHOD FOR THE PRODUCTION THEREOF
ATE72756T1 (en) PROCESS FOR PRODUCTION OF A BIOLOGICAL SUBSTANCE.
ATE52890T1 (en) METHOD AND APPARATUS FOR IMPROVING ROEST COFFEE.
AT384032B (en) METHOD FOR PRODUCING POLYDISPERSE NATIVE PSEUDOMONAS-FLAGELLA (H) -ANTIGENS (FAG)
EP0607593A3 (en) Process for obtaining cell cultures with a higher content of autologous cytonines.
ATE30161T1 (en) PROCESS FOR PRODUCTION OF GLOBIN FROM HAEMOGLOBIN AND THE GLOBIN OBTAINED IN THIS PROCESS.
DE3265664D1 (en) Process for the production of a biochemical vaccine against salmonella fevers
ATE100148T1 (en) PROCESS FOR THE PRODUCTION OF HIGHLY UNSATURATED FAT ACIDS.
ATE215784T1 (en) METHOD FOR PRODUCING A KAPPA-CASEIN GLYCOMACROPEPTIDE OR A DERIVATIVE THEREOF
ATE116989T1 (en) METHOD FOR PURIFYING HEMIN, NEW HEMIN DERIVATIVE AND METHOD FOR PRODUCTION.
ATE14596T1 (en) PROCESS FOR THE PREPARATION OF AMMONIUM LACTATE CONTAINING MIXTURES AND APPARATUS FOR CARRYING OUT THE PROCESS.
ATE70452T1 (en) PROCESS FOR PRODUCTION OF A PROPOLIS|THANO EXTRACT.
FR2620726B1 (en) PROCESS FOR THE PREPARATION OF A JASMINE EXTRACT AND EXTRACT OBTAINED
ATE69034T1 (en) PROCESS FOR PRODUCTION OF POLYCHLOROPHOSPHAZEN.
DE59106227D1 (en) METHOD FOR PRODUCING SPAGYRIC ESSENCES FROM PLANTS.
JPS6410950A (en) Elimination of taste and odor of substance rich in amino acid
ATE101393T1 (en) PHENANTHRIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEANS FOR CARRYING OUT THE PROCESS.
SU1564190A1 (en) Method of obtaining preparation of photosynthetic reaction centres containing photoactive citochromes

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time